PBMs Get Aggressive to Keep Their Drug Profits Secret from Consumers
If the makers of Coke or KFC’s famous fried chicken ever fear for keeping their recipes private and confidential, they...
Are You Paying Too Much For Your Prescription? Maybe, But Your Pharmacist Isn’t Allowed To Tell You.
Pharmacy benefit managers (PBMs), which act as intermediaries between pharmaceutical manufacturers, insurers and pharmacies, operate behind the scenes and are...
CASE Op-Ed: Benefits of CVS/Aetna Merger Likely Elusive for Patients and Consumers
Gerard Scimeca, CASE Chairman December 11, 2017 – http://bit.ly/2AbxGBC With the recent $69 billion acquisition of Aetna insurance by CVS —...
CASE Op-Ed: Transparency Is Key to Lower Medicare Part D Costs
http://bit.ly/2EsfFSE Matthew Kandrach, CASE President Government programs don’t have a great track record of coming in under budget, but Medicare...
CASE Op-ed: PBM Reforms Would Save Consumers Millions on Prescription Drugs
Read full article here: by CASE President Matthew Kandrach Pharmacy Benefit Managers (PBMs), the goliath health insurance middle-men wedged between...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/